Showing results (1-10 of 407) with videos related to
Sort By:
Pageof 41
Journal of Chemotherapy (Florence, Italy)|June 1, 1989
In vitro activity of YTR 830M R Jacobs, S C Aronoff, P C Appelbaum, et al.The Journal of Antimicrobial Chemotherapy|August 1, 1986
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonadsM R Jacobs, S C Aronoff, S Johenning, et al.Antimicrobial Agents and Chemotherapy|October 1, 1984
Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillinS C Aronoff, M R Jacobs, S Johenning, et al.The Journal of Antimicrobial Chemotherapy|August 1, 1986
Synergy of amoxycillin combined with clavulanate and YTR 830 in experimental infections in miceS C Aronoff, M R Jacobs, P H Labrozzi, et al.Antimicrobial Agents and Chemotherapy|November 1, 1986
Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobesP C Appelbaum, M R Jacobs, S K Spangler, et al.Antimicrobial Agents and Chemotherapy|June 1, 1986
Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined beta-lactamase-producing aerobic gram-negative bacilliM R Jacobs, S C Aronoff, S Johenning, et al.International Journal of Antimicrobial Agents|August 29, 2000
Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries. Laser Study GroupM R Jacobs, P C AppelbaumThe Journal of Antimicrobial Chemotherapy|September 1, 1990
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centresM R Jacobs, S K Spangler, P C AppelbaumThe Journal of Antimicrobial Chemotherapy|June 26, 1999
Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniaeL M Kelly, M R Jacobs, P C AppelbaumAntimicrobial Agents and Chemotherapy|December 1, 1994
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinirS K Spangler, M R Jacobs, P C AppelbaumPageof 41